Proteomic analysis in mammary glands of rat offspring exposed in utero to bisphenol A.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 20219716)

Published in J Proteomics on February 26, 2010

Authors

Angela M Betancourt1, James A Mobley, Jose Russo, Coral A Lamartiniere

Author Affiliations

1: Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, AL, USA.

Articles by these authors

SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature (2008) 4.27

Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochim Biophys Acta (2006) 2.76

New developments in profiling and imaging of proteins from tissue sections by MALDI mass spectrometry. J Proteome Res (2006) 2.33

A novel histology-directed strategy for MALDI-MS tissue profiling that improves throughput and cellular specificity in human breast cancer. Mol Cell Proteomics (2006) 2.03

Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index: reproducibility of grade and advantages of proliferation index. Mod Pathol (2005) 1.94

In utero exposure to bisphenol A shifts the window of susceptibility for mammary carcinogenesis in the rat. Environ Health Perspect (2010) 1.75

Processing MALDI Mass Spectra to Improve Mass Spectral Direct Tissue Analysis. Int J Mass Spectrom (2007) 1.73

Structural heterogeneity and protein composition of exosome-like vesicles (prostasomes) in human semen. Prostate (2009) 1.68

Abundant lipid and protein components of drusen. PLoS One (2010) 1.62

Soluble fragment of P-cadherin adhesion protein found in human milk. J Cell Biochem (2002) 1.48

Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells. Biochim Biophys Acta (2012) 1.44

Autophosphorylation in the leucine-rich repeat kinase 2 (LRRK2) GTPase domain modifies kinase and GTP-binding activities. J Mol Biol (2011) 1.42

Reducing cancer disparities for minorities: a multidisciplinary research agenda to improve patient access to health systems, clinical trials, and effective cancer therapy. J Clin Oncol (2006) 1.41

ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approaches. Biochim Biophys Acta (2009) 1.41

Oral exposure to bisphenol a increases dimethylbenzanthracene-induced mammary cancer in rats. Environ Health Perspect (2009) 1.38

MMTV Env encodes an ITAM responsible for transformation of mammary epithelial cells in three-dimensional culture. J Exp Med (2005) 1.34

Resveratrol, but not EGCG, in the diet suppresses DMBA-induced mammary cancer in rats. J Carcinog (2006) 1.33

Resveratrol suppresses prostate cancer progression in transgenic mice. Carcinogenesis (2007) 1.30

Epigallocatechin-3-Gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: mechanisms of action. Prostate (2007) 1.29

Epithelial to mesenchymal transition in human breast epithelial cells transformed by 17beta-estradiol. Cancer Res (2007) 1.23

Estradiol and its metabolites 4-hydroxyestradiol and 2-hydroxyestradiol induce mutations in human breast epithelial cells. Int J Cancer (2006) 1.22

Clustered O-glycans of IgA1: defining macro- and microheterogeneity by use of electron capture/transfer dissociation. Mol Cell Proteomics (2010) 1.21

Sodium/potassium ATPase (Na+, K+-ATPase) and ouabain/related cardiac glycosides: A new paradigm for development of anti- breast cancer drugs? Breast Cancer Res Treat (2005) 1.21

Identification of cripto-1 as a novel serologic marker for breast and colon cancer. Clin Cancer Res (2006) 1.18

Estrogen-mediated epigenetic repression of large chromosomal regions through DNA looping. Genome Res (2010) 1.18

Capsid size determination by Staphylococcus aureus pathogenicity island SaPI1 involves specific incorporation of SaPI1 proteins into procapsids. J Mol Biol (2008) 1.18

Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors. Biochim Biophys Acta (2009) 1.17

LRRK2 secretion in exosomes is regulated by 14-3-3. Hum Mol Genet (2013) 1.15

Genistein chemoprevention of prostate cancer in TRAMP mice. J Carcinog (2007) 1.14

Effect of prenatal exposure to the endocrine disruptor bisphenol A on mammary gland morphology and gene expression signature. J Endocrinol (2008) 1.12

The estrogen antagonist ICI-182-780 does not inhibit the transformation phenotypes induced by 17-beta-estradiol and 4-OH estradiol in human breast epithelial cells. Int J Oncol (2005) 1.12

Dietary genistein down-regulates androgen and estrogen receptor expression in the rat prostate. Mol Cell Endocrinol (2002) 1.11

Pregnancy-induced changes in breast cancer risk. J Mammary Gland Biol Neoplasia (2011) 1.11

Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV-40 tag rats. Prostate (2009) 1.08

Differentiating proteomic biomarkers in breast cancer by laser capture microdissection and MALDI MS. J Proteome Res (2008) 1.05

Epithelial mesenchymal transition during the neoplastic transformation of human breast epithelial cells by estrogen. Int J Oncol (2007) 1.05

Genomic signature induced by pregnancy in the human breast. Int J Oncol (2006) 1.04

Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects. Ann N Y Acad Sci (2009) 1.04

Monitoring mouse prostate development by profiling and imaging mass spectrometry. Mol Cell Proteomics (2007) 1.03

Aurora kinase-A inactivates DNA damage-induced apoptosis and spindle assembly checkpoint response functions of p73. Cancer Cell (2012) 1.02

Formation of depurinating N3Adenine and N7Guanine adducts by MCF-10F cells cultured in the presence of 4-hydroxyestradiol. Int J Cancer (2007) 1.00

Exposure to the Endocrine Disruptor Bisphenol A Alters Susceptibility for Mammary Cancer. Horm Mol Biol Clin Investig (2011) 1.00

17 beta -estradiol-mediated vessel assembly and stabilization in tumor angiogenesis requires TGF beta and EGFR crosstalk. Angiogenesis (2003) 1.00

Regulation of mitochondrial respiratory chain structure and function by estrogens/estrogen receptors and potential physiological/pathophysiological implications. Biochim Biophys Acta (2005) 0.99

Genistein alters growth factor signaling in transgenic prostate model (TRAMP). Mol Cell Endocrinol (2004) 0.99

Chronic oral exposure to bisphenol A results in a nonmonotonic dose response in mammary carcinogenesis and metastasis in MMTV-erbB2 mice. Environ Health Perspect (2011) 0.98

Defining the genomic signature of the parous breast. BMC Med Genomics (2012) 0.97

Histologic changes in the breast with menopausal hormone therapy use: correlation with breast density, estrogen receptor, progesterone receptor, and proliferation indices. Menopause (2008) 0.97

A novel branched-chain amino acid metabolon. Protein-protein interactions in a supramolecular complex. J Biol Chem (2007) 0.97

Integrative approach reveals composition of endoparasitoid wasp venoms. PLoS One (2013) 0.97

Branched-chain amino acid metabolon: interaction of glutamate dehydrogenase with the mitochondrial branched-chain aminotransferase (BCATm). J Biol Chem (2009) 0.96

Imaging mass spectrometry of intact proteins from alcohol-preserved tissue specimens: bypassing formalin fixation. J Proteome Res (2008) 0.96

Prenatal TCDD exposure predisposes for mammary cancer in rats. Reprod Toxicol (2006) 0.95

In utero exposure to butyl benzyl phthalate induces modifications in the morphology and the gene expression profile of the mammary gland: an experimental study in rats. Environ Health (2011) 0.94

S100P calcium-binding protein expression is associated with high-risk proliferative lesions of the breast. Oncol Rep (2006) 0.94

Incorporation of scaffolding protein gpO in bacteriophages P2 and P4. Virology (2007) 0.94

Genistein action in the prepubertal mammary gland in a chemoprevention model. Carcinogenesis (2002) 0.94

Selective profiling of proteins in lung cancer cells from fine-needle aspirates by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Cancer Res (2006) 0.93

Dietary genistein suppresses chemically induced prostate cancer in Lobund-Wistar rats. Cancer Lett (2002) 0.93

ERbeta shifts from mitochondria to nucleus during estrogen-induced neoplastic transformation of human breast epithelial cells and is involved in estrogen-induced synthesis of mitochondrial respiratory chain proteins. Biochim Biophys Acta (2007) 0.93

Endocrine-active chemicals in mammary cancer causation and prevention. J Steroid Biochem Mol Biol (2011) 0.92

Dietary genistein improves survival and reduces expression of osteopontin in the prostate of transgenic mice with prostatic adenocarcinoma (TRAMP). J Nutr (2005) 0.92

Applying proteomic-based biomarker tools for the accurate diagnosis of pancreatic cancer. J Gastrointest Surg (2008) 0.92

Re: The role of SATB1 in breast cancer pathogenesis. J Natl Cancer Inst (2010) 0.92

Expression pattern of a homeotic gene, HOXA5, in normal breast and in breast tumors. Cell Oncol (2006) 0.91

Parasitoid wasp venom SERCA regulates Drosophila calcium levels and inhibits cellular immunity. Proc Natl Acad Sci U S A (2013) 0.91

DNA methylation changes in a human cell model of breast cancer progression. Mutat Res (2010) 0.91

Chemoprevention of breast cancer, proteomic discovery of genistein action in the rat mammary gland. J Nutr (2005) 0.90

Characterization of a genomic signature of pregnancy identified in the breast. Cancer Prev Res (Phila) (2011) 0.89

Genistein and resveratrol: mammary cancer chemoprevention and mechanisms of action in the rat. Expert Rev Anticancer Ther (2006) 0.89

Chemoprevention of breast cancer by fish oil in preclinical models: trials and tribulations. Cancer Res (2011) 0.88

Alternately spliced luteinizing hormone/human chorionic gonadotropin receptor mRNA in human breast epithelial cells. Int J Oncol (2002) 0.87

Mass profiling-directed isolation and identification of a stage-specific serologic protein biomarker of advanced prostate cancer. Proteomics (2005) 0.86

Modeling biological variability in 2-D gel proteomic carcinogenesis experiments. J Proteome Res (2005) 0.86

Cell proliferation and apoptosis in rat mammary glands following combinational exposure to bisphenol A and genistein. BMC Cancer (2014) 0.86

The plasticizer butyl benzyl phthalate induces genomic changes in rat mammary gland after neonatal/prepubertal exposure. BMC Genomics (2007) 0.85

Effect of human chorionic gonadotropin in the gene expression profile of MCF-7 cells. Int J Oncol (2004) 0.85

Vascular endothelial tight junctions and barrier function are disrupted by 15(S)-hydroxyeicosatetraenoic acid partly via protein kinase C ε-mediated zona occludens-1 phosphorylation at threonine 770/772. J Biol Chem (2013) 0.85

Expression and DNA methylation changes in human breast epithelial cells after bisphenol A exposure. Int J Oncol (2012) 0.84

Role of the estrogen antagonist ICI 182,780 in vessel assembly and apoptosis of endothelial cells. Ultrastruct Pathol (2003) 0.84

Validation of a robust proteomic analysis carried out on formalin-fixed paraffin-embedded tissues of the pancreas obtained from mouse and human. Proteomics (2012) 0.83

Identification, virulence, and mass spectrometry of toxic ECP fractions of West Alabama isolates of Aeromonas hydrophila obtained from a 2010 disease outbreak. Vet Microbiol (2013) 0.83

Synthesis and estrogen receptor binding affinities of 7-hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-ones containing a basic side chain. Bioorg Med Chem Lett (2003) 0.83

Altered carcinogenesis and proteome in mammary glands of rats after prepubertal exposures to the hormonally active chemicals bisphenol a and genistein. J Nutr (2012) 0.83

An in vitro-in vivo model of epithelial mesenchymal transition in triple negative breast cancer. Drug Discov Today Dis Mech (2012) 0.83

Hypermethylation of the progesterone receptor A in constitutive antiprogestin-resistant mouse mammary carcinomas. Breast Cancer Res Treat (2010) 0.83

Characterization of FKGK18 as inhibitor of group VIA Ca2+-independent phospholipase A2 (iPLA2β): candidate drug for preventing beta-cell apoptosis and diabetes. PLoS One (2013) 0.82

Primary prevention of breast cancer by hormone-induced differentiation. Recent Results Cancer Res (2007) 0.82

Methodological approach to study the genomic profile of the human breast. Int J Oncol (2007) 0.82

Genetic identification of distinct loci controlling mammary tumor multiplicity, latency, and aggressiveness in the rat. Mamm Genome (2006) 0.82

Self-calibrated warping for mass spectra alignment. Cancer Inform (2011) 0.81

Difference in gene expression profile in breast epithelial cells from women with different reproductive history. Int J Oncol (2003) 0.81